Mednet Logo
HomeHematologyQuestion

Are there any differences in your approach to therapy for secondary versus primary myelofibrosis?

2
1 Answers
Mednet Member
Mednet Member
Medical Oncology · Massachusetts General Hospital

Good question. I will risk stratify patients with secondary MF using the MYSEC-PM score and primary MF patients using DIPSS+ or MIPSS. Anecdotally, patients with secondary MF tend to have more indolent MF and there is definitely a grey zone period when you know they are transforming but still doing ...

Register or Sign In to see full answer